Adherence and healthcare utilization among older adults with COPD and depression

Abstract Background and objective Adherence to chronic obstructive pulmonary disease (COPD) maintenance medications and antidepressants may reduce healthcare utilization among multimorbid individuals with COPD and depression. We quantified the independent effects of adherence to antidepressants and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Respiratory medicine 2017-08, Vol.129, p.53-58
Hauptverfasser: Albrecht, Jennifer S., PhD, Khokhar, Bilal, MA, PhD, Huang, Ting-Ying, PhD, Wei, Yu-Jung, PhD, Harris, Ilene, Pharm D, PhD, Moyo, Patience, MS, Hur, Peter, Pharm D, Lehmann, Susan W., MD, Netzer, Giora, MD, MSCE, Simoni-Wastila, Linda, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 58
container_issue
container_start_page 53
container_title Respiratory medicine
container_volume 129
creator Albrecht, Jennifer S., PhD
Khokhar, Bilal, MA, PhD
Huang, Ting-Ying, PhD
Wei, Yu-Jung, PhD
Harris, Ilene, Pharm D, PhD
Moyo, Patience, MS
Hur, Peter, Pharm D
Lehmann, Susan W., MD
Netzer, Giora, MD, MSCE
Simoni-Wastila, Linda, PhD
description Abstract Background and objective Adherence to chronic obstructive pulmonary disease (COPD) maintenance medications and antidepressants may reduce healthcare utilization among multimorbid individuals with COPD and depression. We quantified the independent effects of adherence to antidepressants and COPD maintenance medications on healthcare utilization among individuals co-diagnosed with COPD and depression. Procedures We conducted a retrospective cohort study using a 2006–2012 5% random sample of Medicare beneficiaries co-diagnosed with COPD and depression who had two or more prescription fills of both COPD maintenance medications and antidepressants. We measured adherence to medications using the proportion of days covered per 30-day period. The primary outcomes were all-cause emergency department (ED) visits and hospitalizations. Beneficiaries were followed over a minimum 12-month follow-up period. Results Of the 16,075 beneficiaries meeting inclusion criteria, 21% achieved adherence ≥80% to COPD maintenance medications and 55% achieved adherence ≥80% to antidepressants. Compared to no use and controlling for antidepressant adherence and potential confounders, higher (≥80%) levels of adherence to COPD maintenance medications were associated with decreased risk of ED visits (hazard ratio (HR) 0.79; 95% CI 0.74, 0.83) and hospitalizations (HR 0.82; 95% CI 0.78, 0.87). Similarly, higher levels (≥80%) of adherence to antidepressants resulted in decreased risk of ED visits (HR 0.74; 95% CI 0.70, 0.78) and hospitalizations (HR 0.77; 95% CI 0.73, 0.81) compared to no use. Conclusions Clinicians can assist in the improved management of their multimorbid patients' health by treating depression among patients with COPD and monitoring and encouraging adherence to the regimens they prescribe.
doi_str_mv 10.1016/j.rmed.2017.06.002
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5607946</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0954611117301683</els_id><sourcerecordid>1922871450</sourcerecordid><originalsourceid>FETCH-LOGICAL-c538t-e22e7c22876293ba40cc3faab2ca34467e013c8f66ce0851632a6657b21fcd1c3</originalsourceid><addsrcrecordid>eNp9kktv1DAUhS0EokPhD7BAkdiwSbh-xEkkVKkanlKlVgLWlse5aTx44sF2isqvx-mUAl2w8sLfObrnnkvIcwoVBSpfb6uww75iQJsKZAXAHpAVrTkrOUjxkKygq0UpKaVH5EmMWwDohIDH5Ii1DWctlytycdqPGHAyWOipL0bULo1GByzmZJ39qZP1U6F3frosvOsxFLqfXYrFD5vGYn1-8fZG1-M-YIyZfUoeDdpFfHb7HpOv7999WX8sz84_fFqfnpWm5m0qkTFsDMuDSNbxjRZgDB-03jCjuRCyQaDctIOUBqGtqeRMS1k3G0YH01PDj8nJwXc_b_IWDE4paKf2we50uFZeW_Xvz2RHdemvVC2h6YTMBq9uDYL_PmNMamejQef0hH6OinaM1dBxLjL68h669XOYcrwbqm2oqCFT7ECZ4GMMONwNQ0EthamtWgpTS2EKpMqFZdGLv2PcSX43lIE3BwDzMq8sBhWNXfrqbUCTVO_t__1P7smNs5M12n3Da4x_cqjIFKjPy8ksF0Mbnh1bzn8BIdG8Ag</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1922871450</pqid></control><display><type>article</type><title>Adherence and healthcare utilization among older adults with COPD and depression</title><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Albrecht, Jennifer S., PhD ; Khokhar, Bilal, MA, PhD ; Huang, Ting-Ying, PhD ; Wei, Yu-Jung, PhD ; Harris, Ilene, Pharm D, PhD ; Moyo, Patience, MS ; Hur, Peter, Pharm D ; Lehmann, Susan W., MD ; Netzer, Giora, MD, MSCE ; Simoni-Wastila, Linda, PhD</creator><creatorcontrib>Albrecht, Jennifer S., PhD ; Khokhar, Bilal, MA, PhD ; Huang, Ting-Ying, PhD ; Wei, Yu-Jung, PhD ; Harris, Ilene, Pharm D, PhD ; Moyo, Patience, MS ; Hur, Peter, Pharm D ; Lehmann, Susan W., MD ; Netzer, Giora, MD, MSCE ; Simoni-Wastila, Linda, PhD</creatorcontrib><description>Abstract Background and objective Adherence to chronic obstructive pulmonary disease (COPD) maintenance medications and antidepressants may reduce healthcare utilization among multimorbid individuals with COPD and depression. We quantified the independent effects of adherence to antidepressants and COPD maintenance medications on healthcare utilization among individuals co-diagnosed with COPD and depression. Procedures We conducted a retrospective cohort study using a 2006–2012 5% random sample of Medicare beneficiaries co-diagnosed with COPD and depression who had two or more prescription fills of both COPD maintenance medications and antidepressants. We measured adherence to medications using the proportion of days covered per 30-day period. The primary outcomes were all-cause emergency department (ED) visits and hospitalizations. Beneficiaries were followed over a minimum 12-month follow-up period. Results Of the 16,075 beneficiaries meeting inclusion criteria, 21% achieved adherence ≥80% to COPD maintenance medications and 55% achieved adherence ≥80% to antidepressants. Compared to no use and controlling for antidepressant adherence and potential confounders, higher (≥80%) levels of adherence to COPD maintenance medications were associated with decreased risk of ED visits (hazard ratio (HR) 0.79; 95% CI 0.74, 0.83) and hospitalizations (HR 0.82; 95% CI 0.78, 0.87). Similarly, higher levels (≥80%) of adherence to antidepressants resulted in decreased risk of ED visits (HR 0.74; 95% CI 0.70, 0.78) and hospitalizations (HR 0.77; 95% CI 0.73, 0.81) compared to no use. Conclusions Clinicians can assist in the improved management of their multimorbid patients' health by treating depression among patients with COPD and monitoring and encouraging adherence to the regimens they prescribe.</description><identifier>ISSN: 0954-6111</identifier><identifier>EISSN: 1532-3064</identifier><identifier>DOI: 10.1016/j.rmed.2017.06.002</identifier><identifier>PMID: 28732836</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adhesion ; Adults ; Antidepressants ; Beneficiaries ; Chronic illnesses ; Chronic obstructive pulmonary disease ; Codes ; Comorbidity ; Depression ; Emergency medical services ; Government programs ; Health care ; Health services utilization ; Healthcare utilization ; Hospitalization ; Lung diseases ; Maintenance ; Medicare ; Medication adherence ; Mental depression ; Mortality ; Obstructive lung disease ; Older people ; Patient compliance ; Patients ; Pharmacy ; Pulmonary/Respiratory ; Risk ; Survival analysis ; Utilization</subject><ispartof>Respiratory medicine, 2017-08, Vol.129, p.53-58</ispartof><rights>2017 Elsevier Ltd</rights><rights>Copyright © 2017 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Aug 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c538t-e22e7c22876293ba40cc3faab2ca34467e013c8f66ce0851632a6657b21fcd1c3</citedby><cites>FETCH-LOGICAL-c538t-e22e7c22876293ba40cc3faab2ca34467e013c8f66ce0851632a6657b21fcd1c3</cites><orcidid>0000-0003-4838-2274</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0954611117301683$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28732836$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Albrecht, Jennifer S., PhD</creatorcontrib><creatorcontrib>Khokhar, Bilal, MA, PhD</creatorcontrib><creatorcontrib>Huang, Ting-Ying, PhD</creatorcontrib><creatorcontrib>Wei, Yu-Jung, PhD</creatorcontrib><creatorcontrib>Harris, Ilene, Pharm D, PhD</creatorcontrib><creatorcontrib>Moyo, Patience, MS</creatorcontrib><creatorcontrib>Hur, Peter, Pharm D</creatorcontrib><creatorcontrib>Lehmann, Susan W., MD</creatorcontrib><creatorcontrib>Netzer, Giora, MD, MSCE</creatorcontrib><creatorcontrib>Simoni-Wastila, Linda, PhD</creatorcontrib><title>Adherence and healthcare utilization among older adults with COPD and depression</title><title>Respiratory medicine</title><addtitle>Respir Med</addtitle><description>Abstract Background and objective Adherence to chronic obstructive pulmonary disease (COPD) maintenance medications and antidepressants may reduce healthcare utilization among multimorbid individuals with COPD and depression. We quantified the independent effects of adherence to antidepressants and COPD maintenance medications on healthcare utilization among individuals co-diagnosed with COPD and depression. Procedures We conducted a retrospective cohort study using a 2006–2012 5% random sample of Medicare beneficiaries co-diagnosed with COPD and depression who had two or more prescription fills of both COPD maintenance medications and antidepressants. We measured adherence to medications using the proportion of days covered per 30-day period. The primary outcomes were all-cause emergency department (ED) visits and hospitalizations. Beneficiaries were followed over a minimum 12-month follow-up period. Results Of the 16,075 beneficiaries meeting inclusion criteria, 21% achieved adherence ≥80% to COPD maintenance medications and 55% achieved adherence ≥80% to antidepressants. Compared to no use and controlling for antidepressant adherence and potential confounders, higher (≥80%) levels of adherence to COPD maintenance medications were associated with decreased risk of ED visits (hazard ratio (HR) 0.79; 95% CI 0.74, 0.83) and hospitalizations (HR 0.82; 95% CI 0.78, 0.87). Similarly, higher levels (≥80%) of adherence to antidepressants resulted in decreased risk of ED visits (HR 0.74; 95% CI 0.70, 0.78) and hospitalizations (HR 0.77; 95% CI 0.73, 0.81) compared to no use. Conclusions Clinicians can assist in the improved management of their multimorbid patients' health by treating depression among patients with COPD and monitoring and encouraging adherence to the regimens they prescribe.</description><subject>Adhesion</subject><subject>Adults</subject><subject>Antidepressants</subject><subject>Beneficiaries</subject><subject>Chronic illnesses</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Codes</subject><subject>Comorbidity</subject><subject>Depression</subject><subject>Emergency medical services</subject><subject>Government programs</subject><subject>Health care</subject><subject>Health services utilization</subject><subject>Healthcare utilization</subject><subject>Hospitalization</subject><subject>Lung diseases</subject><subject>Maintenance</subject><subject>Medicare</subject><subject>Medication adherence</subject><subject>Mental depression</subject><subject>Mortality</subject><subject>Obstructive lung disease</subject><subject>Older people</subject><subject>Patient compliance</subject><subject>Patients</subject><subject>Pharmacy</subject><subject>Pulmonary/Respiratory</subject><subject>Risk</subject><subject>Survival analysis</subject><subject>Utilization</subject><issn>0954-6111</issn><issn>1532-3064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kktv1DAUhS0EokPhD7BAkdiwSbh-xEkkVKkanlKlVgLWlse5aTx44sF2isqvx-mUAl2w8sLfObrnnkvIcwoVBSpfb6uww75iQJsKZAXAHpAVrTkrOUjxkKygq0UpKaVH5EmMWwDohIDH5Ii1DWctlytycdqPGHAyWOipL0bULo1GByzmZJ39qZP1U6F3frosvOsxFLqfXYrFD5vGYn1-8fZG1-M-YIyZfUoeDdpFfHb7HpOv7999WX8sz84_fFqfnpWm5m0qkTFsDMuDSNbxjRZgDB-03jCjuRCyQaDctIOUBqGtqeRMS1k3G0YH01PDj8nJwXc_b_IWDE4paKf2we50uFZeW_Xvz2RHdemvVC2h6YTMBq9uDYL_PmNMamejQef0hH6OinaM1dBxLjL68h669XOYcrwbqm2oqCFT7ECZ4GMMONwNQ0EthamtWgpTS2EKpMqFZdGLv2PcSX43lIE3BwDzMq8sBhWNXfrqbUCTVO_t__1P7smNs5M12n3Da4x_cqjIFKjPy8ksF0Mbnh1bzn8BIdG8Ag</recordid><startdate>20170801</startdate><enddate>20170801</enddate><creator>Albrecht, Jennifer S., PhD</creator><creator>Khokhar, Bilal, MA, PhD</creator><creator>Huang, Ting-Ying, PhD</creator><creator>Wei, Yu-Jung, PhD</creator><creator>Harris, Ilene, Pharm D, PhD</creator><creator>Moyo, Patience, MS</creator><creator>Hur, Peter, Pharm D</creator><creator>Lehmann, Susan W., MD</creator><creator>Netzer, Giora, MD, MSCE</creator><creator>Simoni-Wastila, Linda, PhD</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>ASE</scope><scope>FPQ</scope><scope>H94</scope><scope>K6X</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4838-2274</orcidid></search><sort><creationdate>20170801</creationdate><title>Adherence and healthcare utilization among older adults with COPD and depression</title><author>Albrecht, Jennifer S., PhD ; Khokhar, Bilal, MA, PhD ; Huang, Ting-Ying, PhD ; Wei, Yu-Jung, PhD ; Harris, Ilene, Pharm D, PhD ; Moyo, Patience, MS ; Hur, Peter, Pharm D ; Lehmann, Susan W., MD ; Netzer, Giora, MD, MSCE ; Simoni-Wastila, Linda, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c538t-e22e7c22876293ba40cc3faab2ca34467e013c8f66ce0851632a6657b21fcd1c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adhesion</topic><topic>Adults</topic><topic>Antidepressants</topic><topic>Beneficiaries</topic><topic>Chronic illnesses</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Codes</topic><topic>Comorbidity</topic><topic>Depression</topic><topic>Emergency medical services</topic><topic>Government programs</topic><topic>Health care</topic><topic>Health services utilization</topic><topic>Healthcare utilization</topic><topic>Hospitalization</topic><topic>Lung diseases</topic><topic>Maintenance</topic><topic>Medicare</topic><topic>Medication adherence</topic><topic>Mental depression</topic><topic>Mortality</topic><topic>Obstructive lung disease</topic><topic>Older people</topic><topic>Patient compliance</topic><topic>Patients</topic><topic>Pharmacy</topic><topic>Pulmonary/Respiratory</topic><topic>Risk</topic><topic>Survival analysis</topic><topic>Utilization</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Albrecht, Jennifer S., PhD</creatorcontrib><creatorcontrib>Khokhar, Bilal, MA, PhD</creatorcontrib><creatorcontrib>Huang, Ting-Ying, PhD</creatorcontrib><creatorcontrib>Wei, Yu-Jung, PhD</creatorcontrib><creatorcontrib>Harris, Ilene, Pharm D, PhD</creatorcontrib><creatorcontrib>Moyo, Patience, MS</creatorcontrib><creatorcontrib>Hur, Peter, Pharm D</creatorcontrib><creatorcontrib>Lehmann, Susan W., MD</creatorcontrib><creatorcontrib>Netzer, Giora, MD, MSCE</creatorcontrib><creatorcontrib>Simoni-Wastila, Linda, PhD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Respiratory medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Albrecht, Jennifer S., PhD</au><au>Khokhar, Bilal, MA, PhD</au><au>Huang, Ting-Ying, PhD</au><au>Wei, Yu-Jung, PhD</au><au>Harris, Ilene, Pharm D, PhD</au><au>Moyo, Patience, MS</au><au>Hur, Peter, Pharm D</au><au>Lehmann, Susan W., MD</au><au>Netzer, Giora, MD, MSCE</au><au>Simoni-Wastila, Linda, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adherence and healthcare utilization among older adults with COPD and depression</atitle><jtitle>Respiratory medicine</jtitle><addtitle>Respir Med</addtitle><date>2017-08-01</date><risdate>2017</risdate><volume>129</volume><spage>53</spage><epage>58</epage><pages>53-58</pages><issn>0954-6111</issn><eissn>1532-3064</eissn><abstract>Abstract Background and objective Adherence to chronic obstructive pulmonary disease (COPD) maintenance medications and antidepressants may reduce healthcare utilization among multimorbid individuals with COPD and depression. We quantified the independent effects of adherence to antidepressants and COPD maintenance medications on healthcare utilization among individuals co-diagnosed with COPD and depression. Procedures We conducted a retrospective cohort study using a 2006–2012 5% random sample of Medicare beneficiaries co-diagnosed with COPD and depression who had two or more prescription fills of both COPD maintenance medications and antidepressants. We measured adherence to medications using the proportion of days covered per 30-day period. The primary outcomes were all-cause emergency department (ED) visits and hospitalizations. Beneficiaries were followed over a minimum 12-month follow-up period. Results Of the 16,075 beneficiaries meeting inclusion criteria, 21% achieved adherence ≥80% to COPD maintenance medications and 55% achieved adherence ≥80% to antidepressants. Compared to no use and controlling for antidepressant adherence and potential confounders, higher (≥80%) levels of adherence to COPD maintenance medications were associated with decreased risk of ED visits (hazard ratio (HR) 0.79; 95% CI 0.74, 0.83) and hospitalizations (HR 0.82; 95% CI 0.78, 0.87). Similarly, higher levels (≥80%) of adherence to antidepressants resulted in decreased risk of ED visits (HR 0.74; 95% CI 0.70, 0.78) and hospitalizations (HR 0.77; 95% CI 0.73, 0.81) compared to no use. Conclusions Clinicians can assist in the improved management of their multimorbid patients' health by treating depression among patients with COPD and monitoring and encouraging adherence to the regimens they prescribe.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>28732836</pmid><doi>10.1016/j.rmed.2017.06.002</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-4838-2274</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0954-6111
ispartof Respiratory medicine, 2017-08, Vol.129, p.53-58
issn 0954-6111
1532-3064
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5607946
source Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Adhesion
Adults
Antidepressants
Beneficiaries
Chronic illnesses
Chronic obstructive pulmonary disease
Codes
Comorbidity
Depression
Emergency medical services
Government programs
Health care
Health services utilization
Healthcare utilization
Hospitalization
Lung diseases
Maintenance
Medicare
Medication adherence
Mental depression
Mortality
Obstructive lung disease
Older people
Patient compliance
Patients
Pharmacy
Pulmonary/Respiratory
Risk
Survival analysis
Utilization
title Adherence and healthcare utilization among older adults with COPD and depression
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T01%3A04%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adherence%20and%20healthcare%20utilization%20among%20older%20adults%20with%20COPD%20and%20depression&rft.jtitle=Respiratory%20medicine&rft.au=Albrecht,%20Jennifer%20S.,%20PhD&rft.date=2017-08-01&rft.volume=129&rft.spage=53&rft.epage=58&rft.pages=53-58&rft.issn=0954-6111&rft.eissn=1532-3064&rft_id=info:doi/10.1016/j.rmed.2017.06.002&rft_dat=%3Cproquest_pubme%3E1922871450%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1922871450&rft_id=info:pmid/28732836&rft_els_id=1_s2_0_S0954611117301683&rfr_iscdi=true